Research demonstrates improved solubility and dissolution rate for ticlopidine salts, suggesting better bioavailability for patients.
Ticlopidine (TPD), a Biopharmaceutics Classification System (BCS) class II drug, suffers from poor aqueous solubility, which limits its oral bioavailability. Herein, the enhancement of solubility and dissolution performance of TPD...
No takes yet. Share an insight, caveat, or question.
Saha et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: